drugset / Trial / NCT06344091

A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients

NCT06344091 ↗

Phase 4 Recruiting 232 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelPrevention

Summary

The study is being conducted to evaluate the safety and efficacy of bupivacaine liposome injection for local infiltration analgesia in pediatric orthopedic surgery in the real world.

Timeline

Start
2024-05-21
Primary completion
2026-09-28
Completion
2026-10-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 4 mg/kg Other

Indications

No indication recorded.